LRP8 and lung carcinoma: Additionally, miR-30b-5p has been shown to reduce the viability, migration, and invasion of lung cancer cells by targeting LRP8, suggesting that miR-30b-5p may inhibit lung cancer progression through LRP8 modulation (Qiu et al, 2021).